-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q2 2023.
- Nabriva Therapeutics plc Return On Equity for the quarter ending June 30, 2023 was -2.67K %, a 2708% decline year-over-year.
- Nabriva Therapeutics plc annual Return On Equity for 2022 was -212 %, a 158% decline from 2021.
- Nabriva Therapeutics plc annual Return On Equity for 2021 was -82.1 %, a 60.5% increase from 2020.
- Nabriva Therapeutics plc annual Return On Equity for 2020 was -208 %, a 15.5% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)